No Data
No Data
Goldman Sachs Maintains Neutral on Chemours, Lowers Price Target to $14
J.P. Morgan Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $13
Truist Financial Maintains The Chemours(CC.US) With Buy Rating, Announces Target Price $20
Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $15
Shares of Companies Within the Broader Materials Sector Are Trading Higher Amid Overall Market Strength After the US and China Agreed to a Temporary Reduction in Most Tariffs on Each Other's Goods. A Decrease of Trade Tensions Could Reduce Demand...
Morgan Stanley Maintains Equal-Weight on Chemours, Lowers Price Target to $15